Future Fund LLC Purchases Shares of 44,291 Privia Health Group, Inc. $PRVA

Future Fund LLC acquired a new position in Privia Health Group, Inc. (NASDAQ:PRVA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 44,291 shares of the company’s stock, valued at approximately $1,050,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Hantz Financial Services Inc. grew its stake in shares of Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after acquiring an additional 926 shares during the last quarter. Global Retirement Partners LLC grew its stake in shares of Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after acquiring an additional 1,351 shares during the last quarter. Canada Pension Plan Investment Board grew its stake in shares of Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after acquiring an additional 1,200 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Privia Health Group by 198.5% in the fourth quarter. GAMMA Investing LLC now owns 4,314 shares of the company’s stock worth $102,000 after acquiring an additional 2,869 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Privia Health Group in the second quarter worth $113,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Wall Street Analysts Forecast Growth

PRVA has been the topic of several research analyst reports. Jefferies Financial Group restated a “buy” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Piper Sandler restated an “overweight” rating and issued a $36.00 price objective on shares of Privia Health Group in a research note on Thursday, February 26th. Evercore set a $26.00 price objective on shares of Privia Health Group in a research note on Wednesday, April 8th. Truist Financial raised their price objective on shares of Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Finally, Weiss Ratings downgraded shares of Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.15.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 105,439 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $22.55, for a total value of $2,377,649.45. Following the completion of the transaction, the chief executive officer directly owned 450,004 shares of the company’s stock, valued at $10,147,590.20. This trade represents a 18.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO David Mountcastle sold 7,179 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $25.03, for a total value of $179,690.37. Following the completion of the transaction, the chief financial officer directly owned 214,847 shares of the company’s stock, valued at approximately $5,377,620.41. This trade represents a 3.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 361,330 shares of company stock valued at $8,172,284 over the last ninety days. 5.70% of the stock is owned by company insiders.

Privia Health Group Price Performance

Shares of PRVA stock opened at $21.51 on Friday. The stock has a market cap of $2.71 billion, a P/E ratio of 134.45, a price-to-earnings-growth ratio of 1.73 and a beta of 0.96. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51. The stock has a fifty day moving average price of $22.65 and a 200 day moving average price of $23.07.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Thursday, May 7th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.08 by $0.11. The firm had revenue of $603.85 million during the quarter, compared to analysts’ expectations of $560.99 million. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.Privia Health Group’s quarterly revenue was up 25.8% compared to the same quarter last year. During the same period last year, the business earned $0.22 earnings per share. Equities research analysts anticipate that Privia Health Group, Inc. will post 0.32 EPS for the current year.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.